Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) kicked off on Friday, up 6.36% from the previous trading day, before settling in for the closing price of $2.36. Over the past 52 weeks, MRVI has traded in a range of $1.66-$9.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -64.27% over the past five years. While this was happening, its average annual earnings per share was recorded -212.85%. With a float of $103.37 million, this company’s outstanding shares have now reached $144.62 million.
Maravai LifeSciences Holdings Inc (MRVI) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Maravai LifeSciences Holdings Inc is 28.55%, while institutional ownership is 77.23%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.02 earnings per share (EPS), lower than consensus estimate (set at -0.01) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -212.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.72% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Take a look at Maravai LifeSciences Holdings Inc’s (MRVI) current performance indicators. Last quarter, stock had a quick ratio of 4.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) saw its 5-day average volume 0.83 million, a negative change from its year-to-date volume of 2.32 million. As of the previous 9 days, the stock’s Stochastic %D was 49.34%.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 66.80%, which indicates a significant increase from 53.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was lower than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.48, while its 200-day Moving Average is $3.25. Nevertheless, the first resistance level for the watch stands at $2.60 in the near term. At $2.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.81. If the price goes on to break the first support level at $2.39, it is likely to go to the next support level at $2.28. Assuming the price breaks the second support level, the third support level stands at $2.18.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
The company with the Market Capitalisation of 640.96 million has total of 255,362K Shares Outstanding. Its annual sales at the moment are 259,190 K in contrast with the sum of -144,850 K annual income. Company’s last quarter sales were recorded 47,400 K and last quarter income was -39,590 K.
